<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Mueller, Linda</dc:creator>
  <dc:creator>Cimen, Cansu</dc:creator>
  <dc:creator>Poirel, Laurent </dc:creator>
  <dc:creator>Descombes, Marie-Christine</dc:creator>
  <dc:creator>Nordmann, Patrice</dc:creator>
  <dc:date>2019-05-01</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Our aim was to evaluate the prevalence of fosfomycin-resistant strains among ESBL- producing Escherichia coli isolates recovered from community patients in Switzerland.  A total of 1225 ESBL-producing E. coli isolates were collected between 2012 and  2013 from a private and community laboratory. Fosfomycin resistance was assessed  by using the novel rapid fosfomycin/E. coli NP test and agar dilution method.  Resistant isolates were further investigated for acquired resistance genes fosA1–7 by  PCR and sequencing. Pulsed-field gel electrophoresis (PFGE) and multilocus  sequence typing (MLST) were performed to evaluate the clonal relationship among  fosA3-carrying isolates. Out of the 1225 ESBL-producing E. coli isolates analyzed in  this study, 1208 were fosfomycin susceptible while 17 were fosfomycin resistant. No  discrepancy was observed between the rapid fosfomycin/E. coli NP test and the agar  dilution method taken as the gold standard. Five out of the 17 resistant isolates  carried a fosA-like gene. No clonal relationship was observed among those isolates.  Here, the prevalence of fosfomycin resistance among ESBL-producing E. coli isolates  in the community is reported for the first time in Switzerland, being ca. 1.4%. Among  the five isolates carrying a fosA gene, four encoded the FosA3 enzyme, being the  most prevalent fosfomycin-resistant determinant. An excellent correlation was  observed between minimum inhibitory concentration–based susceptibility  categorization and results of the rapid fosfomycin/E. coli NP test, further indicating the  excellent sensitivity and specificity of this recently developed rapid test whose results  are obtained in less than 2 h.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://folia.unifr.ch/global/documents/307768</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/307768/files/nor_pfr.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1007/s10096-019-03531-0</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>License undefined</dc:rights>
  <dc:source>European Journal of Clinical Microbiology &amp; Infectious Diseases. - 2019, vol. 38, no. 5, p. 945–949</dc:source>
  <dc:subject>info:eu-repo/classification/udc/57</dc:subject>
  <dc:title xmlns:ns1="xml" ns1:lang="en">Prevalence of fosfomycin resistance among ESBL-producing Escherichia coli isolates in the community, Switzerland</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
